Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00320086 · ClinicalTrials.gov registry record
Microalbuminuria in Children With and Without Diabetes
A clinical trial, sponsored by University of New Mexico.
- Completed
- Registry status
- 203
- Enrollment target
NCT00320086: Completed study, sponsored by University of New Mexico.
NCT00320086 is a clinical trial that has completed, run by University of New Mexico. The registered enrollment target is 203 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00320086 has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- 203 participants
- Enrollment target
Study Summary
The purpose of the study is to learn more about Microalbuminuria in children with and without diabetes. Albumin is a protein that may be excreted in the urine. In some conditions, like kidney problems or diabetes, the amount of albumin in the urine increases. The purpose of this study is to measure concentration of albumin in the urine of diabetic children and compare to healthy children.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2005-08 |
| Est. Completion | 2009-03 |
What the finished NCT00320086 record still lists
NCT00320086 is an observational study that tracks outcomes without assigning an intervention. The registered 203 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00320086 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00320086 about?
NCT00320086 is a clinical study titled "Microalbuminuria in Children With and Without Diabetes". The purpose of the study is to learn more about Microalbuminuria in children with and without diabetes. Albumin is a protein that may be excreted in the urine. In some conditions, like kidney problems or diabetes, the amount of albumin in the urine increases. The purpose of this study is to measure ...
What is the current status of trial NCT00320086?
This trial is currently completed. The enrollment target is 203 participants. The study started on 2005-08. Estimated completion is 2009-03.
Who is sponsoring clinical trial NCT00320086?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05652686 · 203 participants · Phase 1
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
- NCT06063122 · 203 participants · NA
Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants
- NCT07031245 · 203 participants · NA
Evidence-Based Quality Improvement to Reduce VA Primary Care Burnout
- NCT03481010 · 204 participants · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia